Found: 261
Select item for more details and to access through your institution.
Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis.
- Published in:
- Rheumatology, 2024, v. 63, n. 11, p. 3124, doi. 10.1093/rheumatology/keae150
- By:
- Publication type:
- Article
A modified Delphi exercise in physician-perceived risk factors for drug-induced pneumotoxicity in patients with rheumatological disease.
- Published in:
- BMC Pulmonary Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12890-024-03287-0
- By:
- Publication type:
- Article
Economic and Health Care Resource Use Burden of Systemic Sclerosis.
- Published in:
- ACR Open Rheumatology, 2023, v. 5, n. 12, p. 677, doi. 10.1002/acr2.11616
- By:
- Publication type:
- Article
Qualitative Interviews to Assess the Content Validity and Usability of the Electronic Raynaud Diary in Patients with Systemic Sclerosis.
- Published in:
- ACR Open Rheumatology, 2023, v. 5, n. 3, p. 132, doi. 10.1002/acr2.11522
- By:
- Publication type:
- Article
Computed Tomography of the Chest to Screen for Interstitial Lung Disease in Patients With Systemic Sclerosis at Expert Scleroderma Centers in the United States.
- Published in:
- ACR Open Rheumatology, 2022, v. 4, n. 7, p. 596, doi. 10.1002/acr2.11434
- By:
- Publication type:
- Article
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database.
- Published in:
- JAMA Dermatology, 2023, v. 159, n. 8, p. 837, doi. 10.1001/jamadermatol.2023.1729
- By:
- Publication type:
- Article
A Practical Approach to the Management of Digital Ulcers in Patients With Systemic Sclerosis: A Narrative Review.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Safety of Tumour Necrosis Factor-α Antagonists.
- Published in:
- Drug Safety, 2004, v. 27, n. 5, p. 307, doi. 10.2165/00002018-200427050-00003
- By:
- Publication type:
- Article
Safety of tumour necrosis factor-alpha antagonists.
- Published in:
- 2004
- By:
- Publication type:
- journal article
COX-2 controversy: where are we and where do we go from here?
- Published in:
- Inflammopharmacology, 2005, v. 13, n. 4, p. 395, doi. 10.1163/156856005774415583
- By:
- Publication type:
- Article
Centromere defects, chromosome instability, and cGAS-STING activation in systemic sclerosis.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-34775-8
- By:
- Publication type:
- Article
Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II).
- Published in:
- Arthritis Research & Therapy, 2019, v. 21, n. 1, p. 1, doi. 10.1186/s13075-019-1809-y
- By:
- Publication type:
- Article
Efficacy and safety during extended treatment of lesinurad in combination with febuxostat in patients with tophaceous gout: CRYSTAL extension study.
- Published in:
- Arthritis Research & Therapy, 2019, v. 21, n. 1, p. 1, doi. 10.1186/s13075-018-1788-4
- By:
- Publication type:
- Article
Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease.
- Published in:
- Arthritis Research & Therapy, 2016, v. 18, p. 1, doi. 10.1186/s13075-016-1203-y
- By:
- Publication type:
- Article
Classifying radiographic progression status in early rheumatoid arthritis patients using propensity scores to adjust for baseline differences.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Synthesis and mechanical properties of novel photosensitive polyimides.
- Published in:
- Polymers for Advanced Technologies, 1993, v. 4, n. 4, p. 234, doi. 10.1002/pat.1993.220040403
- By:
- Publication type:
- Article
Hypothyroidism Is Associated with Increased Mortality in Interstitial Pneumonia with Autoimmune Features.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Functional Characterization of Glycoprotein Nonmetastatic Melanoma Protein B in Scleroderma Fibrosis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.814533
- By:
- Publication type:
- Article
Scleroderma and Fibrosing Disorders: Advances in Management.
- Published in:
- Current Medical Literature: Pulmonary Hypertension, 2011, v. 2, n. 3, p. 77
- By:
- Publication type:
- Article
Health-related quality of life and treatment satisfaction in patients with gout: results from a cross-sectional study in a managed care setting.
- Published in:
- Patient Preference & Adherence, 2015, v. 9, p. 971, doi. 10.2147/PPA.S83700
- By:
- Publication type:
- Article
Congruent microbiome signatures in fibrosis-prone autoimmune diseases: IgG4-related disease and systemic sclerosis.
- Published in:
- Genome Medicine, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13073-021-00853-7
- By:
- Publication type:
- Article
Cardiac metabolomics and autopsy in a patient with early diffuse systemic sclerosis presenting with dyspnea: a case report.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Cardiac metabolomics and autopsy in a patient with early diffuse systemic sclerosis presenting with dyspnea: a case report.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Adherence to Upper-Extremity Home Exercise Delivered via Mobile App for People With Systemic Sclerosis.
- Published in:
- American Journal of Occupational Therapy, 2020, v. 74, p. 1, doi. 10.5014/ajot.2020.74S1-PO6727
- By:
- Publication type:
- Article
Thematic Analysis of Discussion Board Posts from a Self-Management Program for People With Systemic Sclerosis.
- Published in:
- 2017
- By:
- Publication type:
- Abstract
Engagement of Persons With Scleroderma and Stakeholders to Revise a Self- Management Program.
- Published in:
- American Journal of Occupational Therapy, 2016, v. 70, p. 1, doi. 10.5014/ajot.2016.70S1-RP203C
- By:
- Publication type:
- Article
Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis-Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Reliability and minimal clinically important differences of forced vital capacity: Results from the Scleroderma Lung Studies (SLS-I and SLS-II).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Screening and Early Detection of Pulmonary Arterial Hypertension in Connective Tissue Diseases. It Is Time to Institute It!
- Published in:
- 2015
- By:
- Publication type:
- journal article
Impact of a resilience-building energy management intervention for people with systemic sclerosis: a mixed methods study.
- Published in:
- Rheumatology Advances in Practice, 2024, v. 8, n. 2, p. 1, doi. 10.1093/rap/rkae040
- By:
- Publication type:
- Article
Clinical and psychosocioeconomic impact of COVID-19 pandemic on patients of the Indian Progressive Systemic Sclerosis Registry (IPSSR).
- Published in:
- Rheumatology Advances in Practice, 2021, v. 5, n. 2, p. 1, doi. 10.1093/rap/rkab027
- By:
- Publication type:
- Article
Does diagnosis affect the predictive accuracy of risk assessment tools for juvenile offenders: Conduct Disorder and Attention Deficit Hyperactivity Disorder.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Pulmoner hipertansiyon tanı ve tanımlar.
- Published in:
- Archives of the Turkish Society of Cardiology / Türk Kardiyoloji Derneği Arşivi, 2014, v. 42, n. Supp 1, p. 108
- By:
- Publication type:
- Article
Baseline characteristics of systemic sclerosis patients with restrictive lung disease in a multi‐center US‐based longitudinal registry.
- Published in:
- International Journal of Rheumatic Diseases, 2022, v. 25, n. 2, p. 163, doi. 10.1111/1756-185X.14253
- By:
- Publication type:
- Article
Management of systemic sclerosis‐associated interstitial lung disease in the current era.
- Published in:
- International Journal of Rheumatic Diseases, 2020, v. 23, n. 2, p. 137, doi. 10.1111/1756-185X.13799
- By:
- Publication type:
- Article
Evaluation of Scleroderma Clinical Trials Consortium training recommendations on modified Rodnan skin score assessment in scleroderma.
- Published in:
- International Journal of Rheumatic Diseases, 2019, v. 22, n. 6, p. 1036, doi. 10.1111/1756-185X.13523
- By:
- Publication type:
- Article
Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease–Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities.
- Published in:
- QJM: An International Journal of Medicine, 2019, v. 112, n. 2, p. 81, doi. 10.1093/qjmed/hcy272
- By:
- Publication type:
- Article
Scleroderma and Fibrosing Disorders: Advances in Management.
- Published in:
- International Journal of Advances in Rheumatology, 2010, v. 8, n. 2, p. 53
- By:
- Publication type:
- Article
Correction to: How do patients define Raynaud's phenomenon? Differences between primary and secondary disease.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
How do patients define Raynaud's phenomenon? Differences between primary and secondary disease.
- Published in:
- Clinical Rheumatology, 2021, v. 40, n. 4, p. 1611, doi. 10.1007/s10067-021-05598-7
- By:
- Publication type:
- Article
Collaborative National Quality and Efficacy Registry (CONQUER) for Scleroderma: outcomes from a multicenter US-based systemic sclerosis registry.
- Published in:
- Clinical Rheumatology, 2020, v. 39, n. 1, p. 93, doi. 10.1007/s10067-019-04792-y
- By:
- Publication type:
- Article
Consensus opinion of a North American Working Group regarding the classification of digital ulcers in systemic sclerosis.
- Published in:
- Clinical Rheumatology, 2014, v. 33, n. 2, p. 207, doi. 10.1007/s10067-013-2460-7
- By:
- Publication type:
- Article
A Randomized Study of Scleroderma Health State Values: A Picture Is Worth a Thousand Words, and Quite a Few Utilities.
- Published in:
- Medical Decision Making, 2009, v. 29, n. 1, p. 7, doi. 10.1177/0272989X08322010
- By:
- Publication type:
- Article
Oral Cyclophosphamide for Active Scleroderma Lung Disease: A Decision Analysis.
- Published in:
- Medical Decision Making, 2008, v. 28, n. 6, p. 926, doi. 10.1177/0272989X08317015
- By:
- Publication type:
- Article
Willingness to Pay for a Cure in Patients with Chronic Gout.
- Published in:
- Medical Decision Making, 2008, v. 28, n. 4, p. 606, doi. 10.1177/0272989X08315252
- By:
- Publication type:
- Article
Peer‐Led Symptom Management Intervention to Enhance Resilience in People With Systemic Sclerosis: Mediation Analysis From a Randomized Clinical Trial.
- Published in:
- Arthritis Care & Research, 2024, v. 76, n. 9, p. 1278, doi. 10.1002/acr.25352
- By:
- Publication type:
- Article
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases.
- Published in:
- Arthritis Care & Research, 2024, v. 76, n. 8, p. 1051, doi. 10.1002/acr.25348
- By:
- Publication type:
- Article
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases.
- Published in:
- Arthritis Care & Research, 2024, v. 76, n. 8, p. 1070, doi. 10.1002/acr.25347
- By:
- Publication type:
- Article